Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of the Biased μ-Opioid Receptor Agonist Oliceridine in Hysteroscopic Procedures

NCT07713134 is registered in ClinicalTrials.gov with Tangshan Maternal and Child Health Hospital as lead sponsor.

NCT NCT07713134
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07713134 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of the Biased μ-Opioid Receptor Agonist Oliceridine in Hysteroscopic Procedures
Lead sponsor
Tangshan Maternal and Child Health Hospital
Phase
Not applicable
Overall status
Completed
Start date
August 1, 2025
Completion date
June 30, 2026
Enrollment
225 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

analgeisa, hysteroscopy